← Back
Data updated: Mar 10, 2026
HQ SPCLT PHARMA
CardiovascularNeurologyInfectious Disease
HQ SPCLT PHARMA is a major pharmaceutical company focused on Cardiovascular, Neurology, Infectious Disease. Key products include ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER.
1978
Since
17
Drugs
-
Trials
100
Approved (2yr)
Recent Activity
MEROPENEM 2026-02-17
Labeling
DEXMEDETOMIDINE HYDROCHLORIDE 2026-02-17
Labeling
CEFAZOLIN SODIUM 2026-02-13
Efficacy
CALCIUM GLUCONATE IN SODIUM CHLORIDE 2025-12-30
MEROPENEM 2025-12-11
Labeling
LINEZOLID 2025-12-08
CEFAZOLIN SODIUM 2025-12-01
Manufacturing (CMC)
ESMOLOL HYDROCHLORIDE 2025-10-22
Labeling
MEROPENEM 2025-10-01
Labeling
MEROPENEM 2025-10-01
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 40%
4 drugs
Neurology 30%
3 drugs
Infectious Disease 10%
1 drugs
Dermatology 10%
1 drugs
Oncology 10%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Baxter specialty
Infectious Disease, Cardiovascular, Oncology, Dermatology
Pfizer big-pharma
Oncology, Infectious Disease, Dermatology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Oncology
GE HEALTHCARE specialty
Infectious Disease, Neurology, Cardiovascular, Oncology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Oncology, Cardiovascular
Active (10)
DILTIAZEM HYDROCHLORIDE IN 0.72% SODIUM CHLORIDE ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER DEXMEDETOMIDINE HYDROCHLORIDE LINEZOLID LEVETIRACETAM IN SODIUM CHLORIDE ESMOLOL HYDROCHLORIDE MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER MAGNESIUM SULFATE IN PLASTIC CONTAINER CISPLATIN
Discontinued (7)
Company Info
- First Approval
- 1978-12-19
- Latest
- 2026-02-13
- Applications
- 15